---
schema_version: "secwatch.filing_event.v1"
accession: "0001000228-22-000066"
form_type: "8-K"
ticker: "HSIC"
cik: "0001000228"
company_name: "HENRY SCHEIN INC"
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T16:44:28.054604+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Henry Schein reports record Q3 non-GAAP diluted EPS of $1.15; narrows FY2022 guidance

## Summary
- Q3 net sales $3.1B (-3.5% YoY); internal sales ex-PPE/COVID test kits +6.8% in local currencies.
- GAAP diluted EPS $1.09 vs $1.15; Non-GAAP diluted EPS $1.15 vs $1.10 (record).
- Global Dental internal sales +1.2% local currency; Medical internal sales ex-PPE/COVID +9.3%.
- FY2022 non-GAAP EPS guidance narrowed to $4.79-$4.87; sales growth guidance lowered to ~1.5-2.5%.
- Repurchased 1.2M shares for $90.5M in Q3; $400M remaining in buyback authorization.

## SEC filing metadata
- accession: 0001000228-22-000066
- form_type: 8-K
- ticker: HSIC
- cik: 0001000228
- company_name: HENRY SCHEIN INC
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000228/000100022822000066/0001000228-22-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000228/000100022822000066/hsic-20221101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001000228-22-000066
- JSON: https://secwatch.observer/filing/0001000228-22-000066.json
- Plain text: https://secwatch.observer/filing/0001000228-22-000066.txt

## Key facts
- Earnings Releases
  HENRY SCHEIN INC reported the nine months ended September 24, 2022 results: revenue $9.3 billion, net income $491 million, EPS $3.55. Guidance reaffirmed.
  - Period: the nine months ended September 24, 2022
  - Revenue: $9.3 billion
  - Net income: $491 million
  - EPS: $3.55
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total net sales for the first nine months of 2022 were $9.3 billion, an increase of 2.3% compared with the first nine months of 2021. The 2.3% increase included 2.4% internal growth in local currencies excluding acquisitions and 2.1% growth from acquisitions, offset by a 2.2% decrease related to foreign currency exchange. Sales of PPE and COVID-19 test kits for the first nine months were $991 million, which is $344 million lower than in the prior-year period. When excluding sales of PPE and COVID-19 test kits, our internal sales growth for the first nine months of 2022 in local currencies was 7.3% compared with the prior-year period. ● GAAP net income for the first nine months of 2022 was $491 million, or $3.55 per diluted share, compared with GAAP net income for the first nine months of 2021 of $484 million, or $3.40 per diluted share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000228/000100022822000066/0001000228-22-000066-index.htm
- Earnings Releases
  HENRY SCHEIN INC reported the three months ended September 24, 2022 results: revenue $3.1 billion, net income $150 million, EPS $1.09. Guidance reaffirmed.
  - Period: the three months ended September 24, 2022
  - Revenue: $3.1 billion
  - Net income: $150 million
  - EPS: $1.09
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total net sales for the quarter were $3.1 billion, a decrease of 3.5% compared with the third quarter of 2021. The 3.5% decrease included a 2.4% decrease in local currencies excluding acquisitions, 1.8% growth from acquisitions and a 2.9% decrease related to foreign currency exchange 1 . Sales of PPE and COVID-19 test kits in the third quarter were $244 million, which is $260 million lower than the prior-year period. When excluding sales of PPE and COVID-19 test kits, our third-quarter internal sales growth in local currencies was 6.8% compared with the prior- year period. ● GAAP net income for the quarter was $150 million, or $1.09 per diluted share, compared with third-quarter 2021 GAAP net income of $162 million, or $1.15 per diluted share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000228/000100022822000066/0001000228-22-000066-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.